ISIS 416858

· Ionis Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ISIS 416858, covering 2016-12-13 to 2023-01-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ISIS 416858 Administered Subcutaneously to Participants With End-Stage Renal Disease (ESRD) on Hemodialysis [Phase 2]

See pricing